We are live on ! Find out more
DCM

Diag Capital Management Portfolio holdings

AUM $87.4M
This Fund
S&P 500
This Quarter Est. Return
-15.23%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.4M
AUM Growth
–
Cap. Flow
+$93.9M
Cap. Flow %
107.42%
Top 10 Hldgs %
50.17%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$5.77M
2
ZBH icon
Zimmer Biomet
ZBH
+$5.52M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$5.46M
4
INCY icon
Incyte
INCY
+$4.69M
5
CELG
Celgene Corp
CELG
+$4.66M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.41%
2 Miscellaneous 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIVN icon
26
LivaNova
LIVN
$4.43B
$1.09M 1.25%
+11,974
New +$1.29M
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
$985K 1.13%
+16,256
New +$1.13M
FOMX
28
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$960K 1.1%
+146,432
New +$637K
VRCA icon
29
Verrica Pharmaceuticals
VRCA
$97.7M
$937K 1.07%
+11,495
New +$1.4M
NBIX icon
30
Neurocrine Biosciences
NBIX
$15.7B
$876K 1%
+12,266
New +$1.18M
XRAY icon
31
Dentsply Sirona
XRAY
$2.22B
$757K 0.87%
+20,347
New +$740K
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
$702K 0.8%
+46,485
New +$692K
ARYAU
33
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$522K 0.6%
+50,500
New +$520K
ADMA icon
34
ADMA Biologics
ADMA
$2.09B
$435K 0.5%
+182,100
New +$902K
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$12.3B
$326K 0.37%
+2,890
New +$447K
ARVN icon
36
Arvinas
ARVN
$600M
$311K 0.36%
+24,210
New +$384K
NEOS
37
DELISTED
Neos Therapeutics, Inc
NEOS
$278K 0.32%
+168,642
New +$473K
ANAB icon
38
AnaptysBio
ANAB
$1.67B
$95K 0.11%
+1,493
New +$111K
1
2

Similar funds

JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
RCM
Rimrock Capital Management Irvine, California $71.6M AUM

Diag Capital Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Diag Capital Management, which disclosed 40 positions worth $87.4M. Its ten largest holdings account for 50% of the portfolio.

Its largest position is Baxter International: 85,933 shares worth $5.66M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Miscellaneous.

  • Diag Capital Management's largest Q4 2018 buy was Baxter International: 85,933 shares worth $5.66M.
  • Diag Capital Management's ten largest holdings make up 50% of its $87.4M portfolio in Q4 2018.
  • Diag Capital Management disclosed 40 positions in Q4 2018, its first 13F filing on record.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.